Na Cocer Peptides bin rayt am 
29 dez bifo.
di nεv sεstem de rεgεl di kכgnishכn, imyushכn, εn di bכdi fכnshכn dεm tru kכmpleks nyurotransmit nεtwכk dεm εn sεlyul signal path dεm. Damej ɔr degeneration insay dis sistɛm kin mek yu gɛt big big wɛl bɔdi prɔblɛm lɛk Alzaima, Pakinsin sik, wɔri, pwɛl hat, ɛn nyural trauma. di kכr path dεm fכ mεnten nyurolכjik εn kכgnitiv hεlth-inklud nyuroprotεkshכn, kכgnitiv εnhansmεnt, imoshכnal rεgulεshכn, εn nyural injuri rεpεr- de dip pan prεsis intavεnshכn dεm fכ nyuronal sכvayvεns, sinaptik plastisiti, nyuroinflameshכn, εn rigεnεraytiv mεkanism dεm. di pεptida sכbstans dεm, wit dεn hכy bayolojikal aktiviti εn blכd-bren barεri pεrmiabiliti, dεn kכmכt as ideal mכlikul dεm fכ tכk bכt nyural path dεm. dεn de delay nyurodijεnεreshכn na di sεl lεvεl εn de protεkt fכnshכnal ripa, we de opin nyu dairekshכn fכ di prεvεnshכn εn tritmεnt fכ nyurolכjik dizכrd.
Figure 1 Proposed pathogenic mεkanism dεm fכ fכnshכnal kכgnitiv dizכrd dεm. Sos: Fכnshכnal kכgnitiv dizכrd: Biyond pseudodementia (2024).
Mekanism ɛn Klinik Valyu fɔ di Kɔr Aplikeshɔn Ɛria dɛn
1. Nyuroprotεkshכn: Mכltidimεnshכnal Difεns Agens Nyurodijεnεraytiv Dεmεj
di pεptida sכbstans dεm de kכnstrכkt difensiv barεri fכ di nεv sεl dεm tru antioksidεshכn, anti-inflameshכn, εn maytochכndrial protεkshכn.
Mitigating oksidativ strɛs damej
di maytochכndria-tכgεt pεpti dεm (εgz., SS-31) de εmbεd insay di maytochכndrial inana mεmbran, we de inhεbit εksyכs riaktiv כksijεn spεs (ROS) prodakshכn. dis de protεkt di maytochכndrial DNA εn di mεmbran integriti, we de dilay nyuronal apoptosis. insay mכdel dεm fכ ischemic strok εn Parkinson in sik, dεn pεpti dεm ya de ridyus di dopaminεrjik nyuron lכs bכku bכku wan.
Inhibit nyuroinflammatory kaskad dɛm
sכm pεpti dεm (εgz., Sεribrolysin), as nyuropεptida kכmpleks dεm, de dכwnrεgul di NF-κB inflammatory pathway. dεn de ridyus εksyכs maykroglial aktibכshכn εn β-amyloid (Aβ)-indyus inflammatory rispכns dεm we dεn de promuot di εksprεshכn fכ nyurotrofik fכktכ dεm (BDNF, NGF), we de mεnten wan maykro envayroment we kכndus fכ nyuronal sכvayvεns.
Fɔ protɛkt di tin we de ambɔg di blɔd ɛn di bren
di pεptayd dεm lεk TB 500 de εnhans di εksprεshכn fכ tayt jכnkshכn protin dεm na di vaskulεr εndoteyl sεl dεm, we de ridyus di pεnεtreshכn fכ harmful sכbstans dεm. dis patikyula mitigate di risk fכ bren εdima εn nyuronal nεkrכsis insay traumatik bren injuri.
2. Kכgnitiv εnhansmεnt: εnhans Sinaptik Plastisiti εn Mεmכri Fכnshכn
we dεn aim fכ di kכgnitiv dεklin εn di lanin-mεmכri impεryans, pεptida sכbstans dεm de akt bay we dεn de rεgεl nyurotransmitta dεm εn sinaptik strכkchכ dεm.
sinaptik εnhansmεnt bay nootropik pεptida dεm
sכm pεpti dεm (εgz., Sema) de mεk di aktvכti fכ di tayrotropin-rilis כmon, we de protεkt di rilis fכ dopamin εn nכrepinephrine. dis de εnhans di sinaptik plastisiti na di hipokampus, we de impruv spatial mεmכri insay di Alzaima sik mכdel dεm. Klinik stכdi dεm sho se dεn kin εlevεt kכgnitiv skכ dεm εn infכmeshכn prכsεsin spid.
Kolinεrjik sistεm rεgulεshכn
sכm cholinergic-mimicking pεpti dεm de εnhans asetilkolin transmishכn efyushכn εn impruv kolεn kכnsantreshכn insay sinaptik kleft dεm, we de hכl pכtεnshal fכ intavεn in mild kכgnitiv impεryans εn postכpεraytiv kכgnitiv dεklin.
Anti-amiloid dipɔzishɔn: .
Aβ-target sikεns dεm (εgz., pεptida sεgmεnt 176–191) de inhεbit Aβ fibril agregεshכn, we de ridyus di fכmeshכn fכ nyurotoksik plek dεm εn delay di patכlayz prכgreshכn fכ Alzaima sik, we de mek dεn bi risεch hotspot fכ εli intavεnshכn.
3. Imoshכnal Rεgulεshכn: Rishεp Nyurotransmitεr Bεlεns εn Strεs Rispכns
di pεptida sכbstans dεm de intavεn insay di mכd dizכrd lεk wae yu de wɔri εn diprεshכn bay we dεn de akt pan di limbik sistεm εn nyuroεndokrin aks.
5-HT pathεy mכdulashכn
sכm pεpti dεm (εgz., Selank), as positifu mכdulet dεm fכ GABA_A rεsεpכta dεm, de εnhans γ-aminobutyric acid (GABA) inhibitory transmishכn, we de εlεviet di anxiety simptom dεm kwik kwik wan. di spid we dεn bigin εn di sef prכfayl pas tradishכnal bεnzodiazepin dεm. di tachykinin rεsεptכr antagonist pεpti dεm de impruv anhedonia insay diprεshכn bay we dεn de inhεbit sכbstans P rilis.
HPA aks rεgulεshכn
di pεptayd dεm lεk כksitosin de εnhans di prεfrכnt kכtikal rεguleshכn fכ di amigdala, we de ridyus di strεs כmon kכtisol lεvεl dεm. Dis kin mek di imɔshɔnal mɛmori prɔsesin bɛtɛ na sɔshal wɔri ɛn post-traumatik strɛs disɔda (PTSD).
Nyuroplastisiti ripa
BDNF-dεriv pεpti dεm de promuot di dεndritik spayna growth in hipokamp nyuron dεm, rεstכr di sinaptik dεnsiti we dεn rεdכks bay krכnik strεs εn rεpεr imyushכnal rεguleshכn fכnshכn dεm na di strכkchכral lεvεl.
4. Nyural Injuri Ripa: Aktibכt Rijεnεraytiv Program dεm εn Axonal Rigrכw
fכ injuri dεm we nכ de rivεrs lεk spεnal kכd injuri εn pεrifεral nyuropathy, pεptida sכbstans dεm de כvakom di inhibitory maykro envayroment fכ rigεnεreshכn.
Fɔ mek di aksɔn gro
NGF-mimik pεpti dεm de aktibכt TrkA rεsεpכta dεm, we de indyuz nyuronal aksכn εlongeshכn. insay sciatic nεv injuri mכdel dεm, dεn de aksεlεrayt aksכnal rigrכw εn impruv mכtal fכnshכn rεkכvεshכn. di pεpti dεm we rilet to di chondroitinase (εgz., Chonluten) de dεgrεd inhibitory proteoglycans lεk chondroitin sulfate, we de klia ska barεri dεm afta spεnal kכd injuri.
rεgulεt di Schwann sεl fכnshכn
di gεstrointestinal protεktiv pεpti dεm (εgz., BPC-157) de protεkt di Schwann sεl proliferashכn εn myelin fכmeshכn, impruv nεv kכndukshכn vεlositi insay dayabεtik pεrifεral nyuropati εn de εliviet pen εn sεns abnכmaliti dεm.
Stem sel mobilizεshכn εn difrεns
FGF-2-dεriv pεpti dεm de indyuz εndojεnik nyural stεm sεl dεm fכ muv to injuri sayt dεm εn difrεnt to fכnshכnal nyuron dεm εn glial sεl dεm, we de gi sεlyul bεsis fכ sεntri nεv sistεm rigεnεreshכn.
Dɔn
di aplikeshכn fכ pεptida sכbstans dεm na nyurolכjik εn kכgnitiv hεlth de mak wan shift frכm 'simptom rilif' to 'nyural rigεnεreshכn' insay tεrapi paradaym dεm. bay we dεn de tכk bכt כksidεtiv strεs, sinaptik fכnshכn, nyuroinflamεshכn, εn rigεnεraytiv path dεm, dεn sכbstans dεm ya de sho mכlti-mεkanik sinagεstik advantej dεm na nyuroprotεkshכn, kכgnitiv εnhansmεnt, imyushכnal rεguleshכn, εn injuri ripa—patikul we de sho pכtεnshal we dεn nכ ebul fכ riples insay rεfraktכri nyurodijεnεraytiv sik dεm εn trauma ripa.
ƆL DI ATIKUL ƐN PRODƆKT INFƆMƐSHƆN WE DƐN GI NA DIS WƐBSAYT NA FƆ ƆL FƆ DI INFƆMƐSHƆN ƐN FƆ EDYUKESHƆN.
Di prɔdak dɛn we dɛn gi na dis wɛbsayt na fɔ in vitro risach nɔmɔ. in vitro risach (Latin: *in glas*, we min insay glas) dεn de du am ausayd mכtalman bכdi. Dɛn prɔdak ya nɔto famasitik, dɛn nɔ gɛt di aprɔval frɔm di US Food and Drug Administration (FDA), ɛn dɛn nɔ fɔ yuz dɛn fɔ protɛkt, trit, ɔ mɛn ɛni mɛrɛsin, sik, ɔ sik. Di lɔ nɔ gri fɔ mek dɛn put dɛn tin ya insay mɔtalman ɔ animal bɔdi ɛni we.
